- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04856449
DBT Skills Plus EMDR for BPD and Trauma (TT-BPD)
March 15, 2023 updated by: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
A Pilot Randomized-controlled Study of Dialectical Behavioral Skills Training Plus EMDR for Borderline Personality Disorder and Trauma
Borderline Personality Disorder (BPD) is a severe disorder that frequently co-occurs with post-traumatic stress disorder (PTSD).
The comorbidity of BPD and PTSD is more disabling, predicting lower rates of BPD remission.
Dialectical behavioral skills training (DBT-ST), is a group-delivered training that covers four types of skills: emotion regulation, mindfulness, interpersonal effectiveness and distress tolerance.
As a stand-alone treatment, research suggest that DBT-ST is an efficacious treatment for BPD.
In parallel, EMDR has emerged in last years as an efficacious approach to adult trauma.
However, so far, the efficacy of EMDR to treat trauma in populations with BPD diagnosis has not been tested.
The present pilot randomized-controlled clinical trial aims to test whether a combination of DBT-ST plus EMDR could be efficacious to treat trauma in individuals with BPD.
40 participants will be recruited from the BPD Unit at the Hospital de la Santa Creu I Sant Pau (Barcelona, Spain) and will be randomized (1:1) to DBT-ST + EMDR or DBT-ST alone.
The primary outcome will be the reduction of PTSD symptoms.
In addition, symptom-related variables will be collected before and after the interventions.
This will be the first study to test the combination of DBT-ST and EMDR.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Catalonia
-
Barcelona, Catalonia, Spain, 08025
- Recruiting
- Hospital De La Santa Creu I Sant Pau
-
Contact:
- Juan C Pascual, PhD
- Phone Number: +34935537843
- Email: jpascual@santpau.cat
-
Principal Investigator:
- Joaquim Soler, PhD
-
Sub-Investigator:
- Juan C Pascual, PhD
-
Sub-Investigator:
- Matilde Elices, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- men and women between 18 and 60 years old
- having had adverse childhood experiences and/or current PTSD symptoms
- signed informed consent
Exclusion Criteria:
- lifetime diagnosis of schizophrenia, drug-induced psychosis, organic brain syndrome, bipolar disorder, or mental retardation.
- participation in any psychotherapy during the study or having received DBT or EMDR in the past
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DBT Skills Training
This intervention will consist of a 6-month-group DBT-skills training continuation, in which participants will be trained in mindfulness, emotion regulation, distress tolerance and interpersonal effectiveness.
|
DBT skills training consists of a 6 months training in mindfulness, emotion regulation, interpersonal effectiveness and distress tolerance.
Other Names:
|
|
Active Comparator: Eye Movement Desensitization and Reprocessing (EMDR)
EMDR will consist of individual therapy sessions that will be focused on processing traumatic memories.
Participants will receive up to 16 individual EMDR sessions, of 60 min each.
|
EMDR sessions will be conducted to reprocess trauma-related memories.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Borderline Symptom List 23 (BSL-23)
Time Frame: 1 week
|
The scores range from a 0 to 4, with higher scores indicating a worse outcome.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impact of Events Scale Revised
Time Frame: 1 week
|
The scores range from a 0 to 25, with higher scores indicating a higher impact of the traumatic event (worse outcome)
|
1 week
|
|
Patient Health Questionnaire (PHQ-9)
Time Frame: 2 weeks
|
The scores range from a 0 to 27, with higher scores indicating a worse outcome.
|
2 weeks
|
|
DISSOCIATIVE EXPERIENCES SCALE (DES)
Time Frame: 1 month
|
The scores range from 0 to 100, with higher scores representing a worse outcome.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 6, 2021
Primary Completion (Anticipated)
May 1, 2023
Study Completion (Anticipated)
May 1, 2023
Study Registration Dates
First Submitted
April 8, 2021
First Submitted That Met QC Criteria
April 19, 2021
First Posted (Actual)
April 23, 2021
Study Record Updates
Last Update Posted (Actual)
March 16, 2023
Last Update Submitted That Met QC Criteria
March 15, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIBSP-TLP-2020-105
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma
-
Humacyte, Inc.CompletedTrauma | Trauma Injury | Trauma, Multiple | Trauma BluntUkraine
-
Arrowhead Regional Medical CenterCompletedTrauma Injury | Trauma Blunt | Vascular TraumaUnited States
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedTrauma Injury | Trauma, MultipleTurkey
-
University Hospital, AngersRecruiting
-
Wonju Severance Christian HospitalNational Research Foundation of KoreaCompletedTrauma Injury | Trauma, MultipleKorea, Republic of
-
Rabin Medical CenterIsraeli Ministry of SecurityUnknown
-
Hospital Departamental de VillavicencioCooperative University of Colombia; Clínica PrimaveraRecruitingTrauma Injury | Trauma Patients in ICU | Trauma (Including Fractures) | Trauma Patients | Trauma ICU PatientsColombia
-
Oslo University HospitalUniversity of Oslo; Sunnaas Rehabilitation Hospital; South-Eastern Norway Regional...RecruitingTrauma Injury | Trauma, Multiple | PolytraumaNorway
-
Chang, Steve S., M.D.Santa Barbara Cottage Hospital; Accumetrics, Inc.CompletedHead Injury Trauma BluntUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Francophone Pediatric Resuscitation...Completed
Clinical Trials on Dialectical Behavioral Therapy Skills Training
-
Duke UniversityCompleted
-
University of OregonCompleted
-
Duke UniversityNational Cancer Institute (NCI)CompletedCancer Metastatic to LungUnited States
-
Medical University of South CarolinaNational Cancer Institute (NCI); National Institutes of Health (NIH)Not yet recruiting
-
Rutgers, The State University of New JerseyCompletedEmotional Regulation | AffectUnited States
-
University of Massachusetts, AmherstNational Institute of Mental Health (NIMH); University of ToledoCompletedBorderline Personality DisorderUnited States
-
Medical University of South CarolinaAmerican Cancer Society, Inc.Not yet recruitingSurvivorship
-
University of Maryland, BaltimoreRecruitingSuicide | PsychosisUnited States
-
Centre for Addiction and Mental HealthUniversity of Missouri, St. LouisCompletedSubstance Use Disorders | Alcohol Use DisorderCanada
-
Emory UniversityCompleted